Cas:68609-08-5 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine,2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane manufacturer & supplier

Chemical Name:3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine,2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane

CAS.NO:68609-08-5

Synonyms:Cyclohexanemethanamine,5-amino-1,3,3-trimethyl-,reaction products with bisphenol A diglycidyl ether homopolymer

Molecular Formula:C₃₁H₄₆N₂O₄

Molecular Weight:510.70800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:487ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:95.56000

Exact Mass:510.34600

LogP:6.45710

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Cyclohexanemethanamine,5-amino-1,3,3-trimethyl-,reaction products with bisphenol A diglycidyl ether homopolymer chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cyclohexanemethanamine,5-amino-1,3,3-trimethyl-,reaction products with bisphenol A diglycidyl ether homopolymer physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cyclohexanemethanamine,5-amino-1,3,3-trimethyl-,reaction products with bisphenol A diglycidyl ether homopolymer Use and application,Cyclohexanemethanamine,5-amino-1,3,3-trimethyl-,reaction products with bisphenol A diglycidyl ether homopolymer technical grade,usp/ep/jp grade.

Related News: The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments. 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine,2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane manufacturer The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments. 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine,2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane supplier The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine,2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane vendor Standard respiratory support therapies are used to treat the symptoms and wait for the virus to be cleared by itself. 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine,2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane factory The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.